| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $495.83K | $398.06K | $838.66K | $17.07M | $2.63M |
| R&D | – | – | – | – | – |
| SG&A | $495.83K | $154.99K | $83.72K | $88.13K | $94.98K |
| Operating Income | -$495.83K | -$398.06K | -$838.66K | -$17.07M | -$2.63M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$1.23M | -$4.50M | -$914.80K | -$31.02M | -$2.63M |
| EPS (basic) | 0.0000 | -0.0100 | -0.0100 | -0.2200 | -0.0200 |
| EPS (diluted) | 0.0000 | -0.0100 | -0.0100 | -0.2200 | – |
| Shares (diluted) | $403.04M | $363.54M | $151.68M | $139.90M | – |